The CBL oncogene was first identified as part of a transforming retrovirus which induces mouse pre-B and pro-B cell lymphomas.
As an adaptor protein for receptor protein-tyrosine kinases, it positively regulates receptor protein-tyrosine kinase ubiquitination in a manner dependent upon its variant SH2 and RING finger domains.
Ubiquitination of receptor protein-tyrosine kinases terminates signaling by marking active receptors for degradation.
Applications:Suitable for use in Western Blot, Indirect Flow Cytometry, ELISA